360
Participants
Start Date
October 31, 2006
Study Completion Date
May 31, 2007
TD-5108
Breco Research, Houston
Lead Sponsor
Collaborators (1)
Theravance Biopharma
INDUSTRY
Alfasigma S.p.A.